Benzinga | Sep 24, 2021 05:06AM EDT

UBS Initiates Coverage On Tenet Healthcare with Neutral Rating, Announces Price Target of $83

UBS initiates coverage on Tenet Healthcare (NYSE:THC) with a Neutral rating and announces Price Target of $83.